Ratio Analysis: Unpacking Neogenomics Inc (NEO)’s Price-to-Cash and Price-to-Free Cash Flow

Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.

After finishing at $6.21 in the prior trading day, Neogenomics Inc (NASDAQ: NEO) closed at $6.42, up 3.38%. In other words, the price has increased by $3.38 from its previous closing price. On the day, 2.12 million shares were traded. NEO stock price reached its highest trading level at $6.56 during the session, while it also had its lowest trading level at $6.23.

Ratios:

Our goal is to gain a better understanding of NEO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.94 and its Current Ratio is at 2.05. In the meantime, Its Debt-to-Equity ratio is 0.68 whereas as Long-Term Debt/Eq ratio is at 0.45.

On April 30, 2025, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $9.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 27 ’25 when Kelly Michael Aaron bought 5,000 shares for $7.60 per share. The transaction valued at 38,000 led to the insider holds 5,000 shares of the business.

Stone Warren bought 5,700 shares of NEO for $48,895 on May 12 ’25. The Pres & Chief Operating Officer now owns 108,280 shares after completing the transaction at $8.58 per share. On May 09 ’25, another insider, TETRAULT LYNN A., who serves as the Director of the company, bought 7,000 shares for $8.14 each. As a result, the insider paid 56,974 and bolstered with 7,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NEO now has a Market Capitalization of 826221888 and an Enterprise Value of 1045893888. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.23 while its Price-to-Book (P/B) ratio in mrq is 0.93. Its current Enterprise Value per Revenue stands at 1.556 whereas that against EBITDA is 1591.924.

Stock Price History:

The Beta on a monthly basis for NEO is 1.56, which has changed by -0.5770751 over the last 52 weeks, in comparison to a change of 0.16260707 over the same period for the S&P500. Over the past 52 weeks, NEO has reached a high of $19.11, while it has fallen to a 52-week low of $6.08. The 50-Day Moving Average of the stock is -12.82%, while the 200-Day Moving Average is calculated to be -45.03%.

Shares Statistics:

The stock has traded on average 2.22M shares per day over the past 3-months and 1449450 shares per day over the last 10 days, according to various share statistics. A total of 128.36M shares are outstanding, with a floating share count of 126.92M. Insiders hold about 1.38% of the company’s shares, while institutions hold 96.33% stake in the company. Shares short for NEO as of 1751241600 were 4540073 with a Short Ratio of 2.04, compared to 1748563200 on 5484928. Therefore, it implies a Short% of Shares Outstanding of 4540073 and a Short% of Float of 4.8699997.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.